US Stock MarketDetailed Quotes

Dianthus Therapeutics (DNTH)

Watchlist
  • 86.615
  • -0.775-0.89%
Trading Apr 27 15:19 ET
4.72BMarket Cap-20.62P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Dianthus Therapeutics (DNTH) Revenue Breakdown Overview

By Business/Source

Currency:USD
2025/FY
Stock NameRevenueRatio
Developing next-generation therapies to transform the treatment of severe autoimmune diseases2.04M100.00%

By Country/Region

Currency:USD
2025/FY
Stock NameRevenueRatio
United States2.04M100.00%
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +20.16%
Sample Name
Sample Code
 +8.45%
Sample Name
Sample Code
 +7.83%
4
VanEck Oil Services ETF
OIH
+6.14%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.92%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +10.55%
Sample Name
Sample Code
 +7.05%
Sample Name
Sample Code
 +4.99%
4
Chagee Holdings
CHA
+3.76%
5
Qifu Technology
QFIN
+0.86%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Lebanese media reports, in the early hours of the 27th local time, Iran conveyed a three-phase negotiation plan to the US throu Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -